1. Home
  2. GCT vs VOR Comparison

GCT vs VOR Comparison

Compare GCT & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GigaCloud Technology Inc

GCT

GigaCloud Technology Inc

HOLD

Current Price

$50.03

Market Cap

1.2B

ML Signal

HOLD

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$23.18

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCT
VOR
Founded
2019
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
GCT
VOR
Price
$50.03
$23.18
Analyst Decision
Strong Buy
Buy
Analyst Count
1
10
Target Price
$33.00
$45.33
AVG Volume (30 Days)
728.4K
824.8K
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
17.70
N/A
EPS
2.19
N/A
Revenue
$1,161,042,000.00
N/A
Revenue This Year
$14.43
N/A
Revenue Next Year
$6.78
N/A
P/E Ratio
$23.49
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.17
$1.90
52 Week High
$56.27
$49.95

Technical Indicators

Market Signals
Indicator
GCT
VOR
Relative Strength Index (RSI) 78.49 66.31
Support Level $36.09 $11.62
Resistance Level N/A N/A
Average True Range (ATR) 2.75 1.30
MACD 1.19 0.21
Stochastic Oscillator 79.54 78.34

Price Performance

Historical Comparison
GCT
VOR

About GCT GigaCloud Technology Inc

GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia with resellers in the U.S., Asia, and Europe to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price. It earns the majority of its revenue from the United States.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: